<DOC>
	<DOCNO>NCT01559922</DOCNO>
	<brief_summary>The purpose study determine whether Artefill safe effective correction atrophic facial acne scar .</brief_summary>
	<brief_title>Use ArtefillÂ® Moderate Severe Atrophic Acne Scar Correction</brief_title>
	<detailed_description>This multi-center , randomize , double-blind , placebo-controlled study assess efficacy safety Artefill correction moderate severe atrophic acne scar . The study divide two study period . In Period I , scar meet treatment criterion individually identify , number map use photographs transparent sheet prior treatment . This mapping use track individual scar throughout trial . Four ( 4 ) week follow baseline qualification visit , subject randomize treatment receive one treatment Artefill Control ( saline ) , administer Treating Investigator . At 72 hour follow injection , subject followed-up telephone confirm occurrence AEs . Subjects return clinic 2 week follow-up evaluation , 4 week subject may receive one optional touch-up treatment . Subjects receive touch-up treatment followed-up telephone 72 hour confirm occurrence AEs , return clinic visit 6 week 8 week . All subject return clinic follow-up month 3 6 ( last treatment ) . Period II open label begin month 6 . Artefill group subject return clinic assessment month 9 12 ( Track A ) Control group subject enter Track B , re-establish baseline , complete additional month 6 visit activity include Artefill treatment . Subjects receive touch ( require ) 4 week later , follow additional 12 month . Subjects require abstain aesthetic treatment face study period failure consider protocol violation . However , subject receive additional aesthetic non-aesthetic treatment , available information treatment collect subject continue follow per protocol . Such subject exclude analysis , also evaluate separately .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Polymethyl Methacrylate</mesh_term>
	<criteria>1 . Subject must outpatient , male female subject race , 18 year age old . Female subject childbearing potential must negative urine pregnancy test result Baseline practice reliable method contraception throughout study . 2 . Subject must moderate severe atrophic acne scar 3 . Subject must desire correction his/her moderate severe acne scarring . 4 . Subjects Fitzpatrick skin type eligible . 5 . Subject must willing withhold additional aesthetic therapy face ( eg , soft tissue filler : Restylane , Radiesse , Sculptra , and/or resurface procedure duration study . 6 . Subject must able follow study instruction likely complete require visit , assess Investigator . 7 . Subject must sign IRBapproved Informed Consent form , Photographic Release Form , Authorization Use release Health Research Study Information ( HIPAA ) form prior studyrelated procedure perform 1 . Female subject pregnant ( positive urine pregnancy test ) , breastfeed , childbearing potential practicing reliable method birth control . 2 . Undergo facial treatment list prohibited treatment/procedures and/or use prohibit treatment/procedure within certain time period . 3 . Have skin pathology condition could interfere evaluation treatment area , worsen due propose treatment require interfere topical , systemic surgical therapy . 4 . Have recent current history inflammatory skin disease , infection , cancerous/precancerous lesion , unhealed wound clinically significant acne propose treatment area . Clinically significant acne define patient &gt; 3 active inflammatory acne lesion either right left treatment area . 5 . Have history systemic granulomatous disease active inactive ( eg , Sarcoid , Wegeners , TB , etc . ) connective tissue disease ( eg , lupus , dermatomyositis , etc. ) . 6 . Have hypertrophic acne scar , evidence keloid scarring , predominantly icepick scarring ( define half scar area either leave right treatment area ) sinus tract scar . 7 . Have know hypersensitivity previous allergic reaction component study device ( include lidocaine amidebased anesthetic ) , history allergy bovine collagen product , include limited injectable collagen , collagen implant , hemostatic sponge , collagenbased suture .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Acne</keyword>
</DOC>